NIVABUPA - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.5
| Stock Code | NIVABUPA | Market Cap | 15,454 Cr. | Current Price | 83.6 ₹ | High / Low | 94.0 ₹ |
| Stock P/E | 118 | Book Value | 20.5 ₹ | Dividend Yield | 0.00 % | ROCE | 3.45 % |
| ROE | 3.82 % | Face Value | 10.0 ₹ | DMA 50 | 78.8 ₹ | DMA 200 | 77.7 ₹ |
| Chg in FII Hold | 0.29 % | Chg in DII Hold | 0.45 % | PAT Qtr | 345 Cr. | PAT Prev Qtr | -87.6 Cr. |
| RSI | 59.9 | MACD | 1.87 | Volume | 7,97,441 | Avg Vol 1Wk | 29,60,466 |
| Low price | 67.5 ₹ | High price | 94.0 ₹ | PEG Ratio | 0.93 | Debt to equity | 0.07 |
| 52w Index | 60.8 % | Qtr Profit Var | 67.5 % | EPS | 0.71 ₹ | Industry PE | 42.7 |
📊 Analysis: NIVABUPA shows moderate intraday potential. Current price (₹83.6) is above DMA 50 (₹78.8) and DMA 200 (₹77.7), reflecting short-term strength. RSI at 59.9 indicates healthy momentum, while MACD (1.87) confirms mild bullish bias. Volume (7.9L) is significantly below the 1-week average (29.6L), showing weak participation. Fundamentals remain weak with high P/E (118 vs industry 42.7), low ROE (3.82%) and ROCE (3.45%), though PAT recovery (₹-87.6 Cr → ₹345 Cr) is a positive sign.
💹 Optimal Buy Price: ₹82–84 if sustained above VWAP with strong intraday volume.
🎯 Profit Exit Levels: ₹86 (near resistance) and ₹88–90 (next resistance zone).
🛑 Stop-Loss: ₹80 (below intraday support).
⏱️ If Already Holding: Exit near ₹86–90 if RSI approaches 65 or momentum slows. Cut positions if price breaks below ₹80 with rising volume pressure.
Positive
- Price trading above DMA 50 and DMA 200, confirming short-term strength.
- Quarterly PAT recovery (₹-87.6 Cr → ₹345 Cr) highlights turnaround.
- FII (+0.29%) and DII (+0.45%) holdings increased, showing institutional support.
- Debt-to-equity ratio at 0.07 indicates low leverage.
Limitation
- Extremely high P/E (118) compared to industry average (42.7).
- Weak ROE (3.82%) and ROCE (3.45%) highlight poor efficiency.
- EPS of ₹0.71 remains low.
- Volume below average, limiting intraday conviction.
- No dividend yield (0.00%), offering no income support.
Company Negative News
- 52-week index at 60.8% indicates weak long-term performance.
- Efficiency metrics remain poor despite profit recovery.
Company Positive News
- Quarterly profit variation positive at 67.5%.
- Institutional holdings (FII + DII) both increased, showing investor confidence.
- PAT recovery supports sentiment.
Industry
- Industry P/E at 42.7 indicates sector is moderately valued compared to NIVABUPA (118).
- Insurance and healthcare sector benefiting from rising demand and policy support.
Conclusion
⚖️ NIVABUPA is a fair candidate for intraday trading with limited upside potential. Buy near ₹82–84 with profit targets at ₹86–90 and stop-loss at ₹80. Momentum indicators support cautious optimism, but high valuation, weak efficiency, and low volume call for conservative trading.
Would you like me to extend this into a swing trade analysis with 1–2 week holding logic, or keep it strictly intraday-focused?